SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in 60 Degrees Pharma

Intracoastal Capital LLC and its principals, Mitchell P. Kopin and Daniel B. Asher, reported a 9.99% beneficial ownership stake in 60 Degrees Pharmaceuticals, Inc. common stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (the "Reporting Persons") collectively reported beneficial ownership of 455,545 shares of 60 Degrees Pharmaceuticals, Inc. common stock.
• This represents 9.99% of the company's common stock, calculated based on 4,104,469 shares outstanding as of September 3, 2025, plus the 455,545 shares issuable from Intracoastal Warrant 1.
• The Reporting Persons hold additional warrants (Intracoastal Warrants 1-7) with blocker provisions that prevent them from exercising the warrants to the extent that their beneficial ownership would exceed 9.99% or 4.99%, depending on the specific warrant.
• Without these blocker provisions, the Reporting Persons would have beneficial ownership of 1,230,169 shares of Common Stock.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a change in previously reported ownership or status.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership by an investment group and does not contain information that would inherently suggest a positive or negative sentiment towards the issuer's operational or financial performance.

Positives

• A significant institutional investor group, Intracoastal Capital LLC, maintains a substantial stake in the company, potentially signaling confidence.
• The existence of blocker provisions in warrants limits the immediate dilution impact on existing shareholders by preventing the holder from exceeding certain ownership thresholds.

Risks

• The presence of multiple warrants with blocker provisions suggests potential future dilution if these provisions are removed or if the ownership thresholds are adjusted, allowing for full exercise.
• A large beneficial ownership by a single group could potentially influence corporate decisions or strategic direction.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of significant ownership and does not provide specific industry context or trends. It indicates an investment in a pharmaceutical company.

Related Party Transactions

• The filing details ownership by Intracoastal Capital LLC and its principals, Mitchell P. Kopin and Daniel B. Asher. While not explicitly labeled 'related party transactions' in the context of the issuer, it represents a significant stake by an external investment group.

Stakeholder Impact

• Shareholders: Disclosure of a significant shareholder group provides transparency regarding the ownership structure. The blocker provisions limit immediate dilution from warrant exercise.

Key Dates

Keywords

60 Degrees Pharmaceuticals, Intracoastal Capital, Mitchell P. Kopin, Daniel B. Asher, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, SEC Filing, Institutional Investor